Search Results 241-250 of 18454 for Tuberous sclerosis
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Faculty members conducting research through the Center for Multiple Sclerosis and Autoimmune Neurology at Mayo Clinic have wide-ranging expertise.
Expanded Access Program with Tirasemtiv for the Treatment of Amyotrophic Lateral Sclerosis (ALS) · Overview · Participation eligibility · Participating Mayo Clinic ...
... Tuberous sclerosis, Neurofibroma, Choroid plexus papilloma, Leptomeningeal metastases, Primary CNS lymphoma. Show more areas of focus for Wendy J. Sherman ...
Translational Neuroimmunology Laboratory of Charles L. Howe, Ph.D., at Mayo Clinic: Studies axon injury to create multiple sclerosis treatments.
... Tuberous sclerosis, Neurofibroma, Choroid plexus papilloma, Leptomeningeal metastases, CNS lymphoma. Show more areas of focus for Wendy J. Sherman, M.D. ...
... sclerosis (ALS). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...
Tuberous sclerosis · Vasovagal syncope · Ventricular fibrillation · Ventricular septal defect (VSD) · Ventricular tachycardia · Wolff-Parkinson-White (WPW) ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.